Chemical activators of transmembrane protein 45A2 (TMEM45A2) can be understood through their specific interactions with various cellular signaling pathways that ultimately lead to the protein's activation. Forskolin is known for its ability to directly stimulate adenylyl cyclase, thereby increasing intracellular levels of cyclic AMP (cAMP). The rise in cAMP activates protein kinase A (PKA), which can phosphorylate numerous cellular proteins, including TMEM45A2, altering its activity state. Similarly, dibutyryl cAMP and 8-Bromo-cAMP, both of which are analogs of cAMP that can permeate cell membranes, also activate PKA, thus potentially facilitating the phosphorylation and subsequent activation of TMEM45A2. Phorbol 12-myristate 13-acetate (PMA) and TPA, despite being the same compound and mistakenly included as separate entities, activate protein kinase C (PKC). PKC plays a pivotal role in phosphorylating serine and threonine residues on target proteins, which may include TMEM45A2, thereby affecting its function.
Ionomycin, by increasing intracellular calcium concentrations, activates calcium-dependent kinases and phosphatases, which can lead to the activation of TMEM45A2 through calcium signaling pathways. Thapsigargin also elevates intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which could similarly result in the activation of TMEM45A2. Okadaic acid and Calyculin A inhibit protein phosphatases like PP1 and PP2A, causing a net increase in the phosphorylation state of cellular proteins, thereby potentially activating TMEM45A2. Epidermal Growth Factor (EGF) engages its receptor, EGFR, initiating a kinase signaling cascade that could lead to the phosphorylation and activation of TMEM45A2. Anisomycin, although primarily a protein synthesis inhibitor, activates stress-activated protein kinases (SAPKs) that can phosphorylate and activate TMEM45A2 as part of the cellular stress response. Lastly, Tetrodotoxin, by altering sodium ion flux and possibly affecting the ion balance within the cell, may trigger compensatory cellular mechanisms that can activate TMEM45A2. Each of these chemicals, through their distinct interactions with cellular components, contribute to the regulatory mechanisms governing the activity state of TMEM45A2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate a wide range of target proteins, potentially including TMEM45A2, as part of signal transduction pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels and thereby activating calcium-sensitive signaling pathways that can lead to the activation of TMEM45A2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation of cellular proteins, which can result in the activation of TMEM45A2 through phosphorylation-dependent mechanisms. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to okadaic acid, inhibits protein phosphatases, leading to increased phosphorylation and potential activation of TMEM45A2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a protein synthesis inhibitor, which paradoxically activates stress-activated protein kinases (SAPKs), potentially leading to the activation of TMEM45A2 through stress response pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing a rise in cytosolic calcium levels and activation of calcium-dependent proteins, potentially including TMEM45A2. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA, which may lead to the activation of TMEM45A2 through cAMP-dependent pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is another cell-permeable cAMP analog that activates PKA, potentially leading to the activation of TMEM45A2 within the PKA signaling pathways. | ||||||